Drug intelligence / Profile preview

Mutagrip

Development stage
Phase 4
Lead developer
Sanofi Pasteur
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Mutagrip is a brand name for a trivalent inactivated influenza vaccine, produced by Sanofi Pasteur. It is formulated to provide active immunization against influenza caused by the specific strains of influenza virus contained in the vaccine, which are selected annually based on World Health Organization (WHO) recommendations. Each standard dose contains 15 micrograms of haemagglutinin antigen per strain for two A strains (H1N1 and H3N2) and one B strain. The vaccine is administered intramuscularly and is indicated for adults and children 6 months of age and older. The mechanism of action involves stimulating an immune response that leads to the production of antibodies against the hemagglutinin surface glycoprotein of the included influenza virus strains, thereby providing protection against infection[3][7].

Brand names
Mutagrip
02

Targets

HA (Hemagglutinin)

Beyond the preview

Go deeper on Mutagrip.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mutagrip.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call